Pouvelle-Moratille S - Search Results

1

NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.

Zarour HM, Maillere B, Brusic V, Coval K, Williams E, Pouvelle-Moratille S, Castelli F, Land S, Bennouna J, Logan T, Kirkwood JM. Zarour HM, et al. Among authors: pouvelle moratille s. Cancer Res. 2002 Jan 1;62(1):213-8. Cancer Res. 2002. PMID: 11782380

2

Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.

Castelli FA, Leleu M, Pouvelle-Moratille S, Farci S, Zarour HM, Andrieu M, Auriault C, Ménez A, Georges B, Maillere B. Castelli FA, et al. Among authors: pouvelle moratille s. Eur J Immunol. 2007 Jun;37(6):1513-23. doi: 10.1002/eji.200636783. Eur J Immunol. 2007. PMID: 17492804 Free article.

3

Emerging principles for the design of promiscuous HLA-DR-restricted peptides: an example from the major bee venom allergen.

Texier C, Pouvelle-Moratille S, Buhot C, Castelli FA, Pecquet C, Ménez A, Leynadier F, Maillère B. Texier C, et al. Among authors: pouvelle moratille s. Eur J Immunol. 2002 Dec;32(12):3699-707. doi: 10.1002/1521-4141(200212)32:12<3699::AID-IMMU3699>3.0.CO;2-V. Eur J Immunol. 2002. PMID: 12516563 Free article.

4

Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family.

Wang XF, Cohen WM, Castelli FA, Almunia C, Lethé B, Pouvelle-Moratille S, Munier G, Charron D, Ménez A, Zarour HM, van der Bruggen P, Busson M, Maillère B. Wang XF, et al. Among authors: pouvelle moratille s. Cancer Immunol Immunother. 2007 Jun;56(6):807-18. doi: 10.1007/s00262-006-0230-y. Epub 2006 Sep 20. Cancer Immunol Immunother. 2007. PMID: 16988823 Free PMC article.

5

HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.

Castelli FA, Buhot C, Sanson A, Zarour H, Pouvelle-Moratille S, Nonn C, Gahery-Ségard H, Guillet JG, Ménez A, Georges B, Maillère B. Castelli FA, et al. Among authors: pouvelle moratille s. J Immunol. 2002 Dec 15;169(12):6928-34. doi: 10.4049/jimmunol.169.12.6928. J Immunol. 2002. PMID: 12471126

6

Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule.

Cohen WM, Pouvelle-Moratille S, Wang XF, Farci S, Munier G, Charron D, Ménez A, Busson M, Maillère B. Cohen WM, et al. Among authors: pouvelle moratille s. J Immunol. 2006 May 1;176(9):5401-8. doi: 10.4049/jimmunol.176.9.5401. J Immunol. 2006. PMID: 16622007

7

T cell epitope-containing peptides of the major dog allergen Can f 1 as candidates for allergen immunotherapy.

Immonen A, Farci S, Taivainen A, Partanen J, Pouvelle-Moratille S, Närvänen A, Kinnunen T, Saarelainen S, Rytkönen-Nissinen M, Maillere B, Virtanen T. Immonen A, et al. Among authors: pouvelle moratille s. J Immunol. 2005 Sep 15;175(6):3614-20. doi: 10.4049/jimmunol.175.6.3614. J Immunol. 2005. PMID: 16148105

8

The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells.

Kinnunen T, Buhot C, Närvänen A, Rytkönen-Nissinen M, Saarelainen S, Pouvelle-Moratille S, Rautiainen J, Taivainen A, Maillère B, Mäntyjärvi R, Virtanen T. Kinnunen T, et al. Among authors: pouvelle moratille s. Eur J Immunol. 2003 Jun;33(6):1717-26. doi: 10.1002/eji.200322952. Eur J Immunol. 2003. PMID: 12778490 Free article.

9

HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.

Gahery H, Figueiredo S, Texier C, Pouvelle-Moratille S, Ourth L, Igea C, Surenaud M, Guillet JG, Maillere B. Gahery H, et al. Among authors: pouvelle moratille s. AIDS Res Hum Retroviruses. 2007 Mar;23(3):427-37. doi: 10.1089/aid.2006.0075. AIDS Res Hum Retroviruses. 2007. PMID: 17411376 Clinical Trial.

10

Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules.

Texier C, Pouvelle-Moratille S, Busson M, Charron D, Ménez A, Maillère B. Texier C, et al. Eur J Immunol. 2001 Jun;31(6):1837-46. doi: 10.1002/1521-4141(200106)31:6<1837::aid-immu1837>3.0.co;2-h. Eur J Immunol. 2001. PMID: 11433380 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters